Contributors

(Image credit: AdobeStock/Atif)

CEO Stephen McLeod, MD, outlines the American Academy of Ophthalmology's commitment to advocating for evidence-based, sustainable, and equitable reforms that prioritize public health and access to quality care.

In a profession that values super subspecialization, combined with a society that pigeonholes physicians into corners, I often felt I didn’t fit into one job title with my varied passions and cross interests.

It’s been a minute, as the Baltimorean’s say, but I still remember my first day of residency. I knew next to nothing about ophthalmology but showed up smiling and eager to learn. I felt incredibly fortunate to be training at such a prestigious institution. I was awed by the distinguished faculty, and my co-residents couldn’t be any more impressive. In short, I wasn’t sure I belonged.

Joseph Panarelli, MD, and Arsham Sheybani, MD, discuss the Primary Trabeculectomy for Advanced Glaucoma: Pragmatic Multicentre Randomized Controlled Trial, or TAGS trial, and how this can apply to real world situation. This multicenter randomized controlled trial evaluated whether primary trabeculectomy or primary medical treatment leads to improved outcomes in terms of quality of life, clinical effectiveness, and safety.